- Record: found
- Abstract: not found
- Article: not found
Unicancer gi prodige 24/cctg pa.6 trial: A multicenter international randomized phase iii trial of adjuvant mfolfirinox versus gemcitabine (gem) in patients with resected pancreatic ductal adenocarcinomas
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.